Monosomy 7 with severe myelodysplasia developing during imatinib treatment of Philadelphia‐positive chronic myeloid leukemia: Two cases with a different outcome
José‐Tomás Navarro(Universitat Autònoma de Barcelona), Fuensanta Millá, Albert Oriol(Institut Català d'Oncologia), Blanca Espinet(Hospital Del Mar), Javier Grau, Dolors Colomer(Hospital Clínic de Barcelona), Josep‐María Ribera(Universitat Autònoma de Barcelona), Evarist Feliú(Universitat Autònoma de Barcelona), Jordi Juncà(Universitat Autònoma de Barcelona), Isabel Granada(Josep Carreras Leukaemia Research Institute)
Cited by 33
Related Papers
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
|Nature|2011|1.5k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Teclistamab in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2022|1.2k
Non-coding recurrent mutations in chronic lymphocytic leukaemia
|Nature|2015|851
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719